Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 400,016 | 310,202 | 249,428 | 174,361 | 36,468 |
| Cost of Goods | 5,087 | 2,731 | 1,037 | 1,089 | N/A |
| Gross Profit | 394,929 | 307,471 | 248,391 | 173,272 | 36,468 |
| Operating Expenses | 440,369 | 378,663 | 308,077 | 225,069 | 222,329 |
| Operating Income | -45,353 | -70,461 | -59,649 | -51,708 | -185,861 |
| Interest Expense | 12,166 | 18,844 | 5,154 | 5,409 | 7,994 |
| Other Income | 38,419 | 36,368 | 3,913 | 16,234 | 65 |
| Pre-tax Income | -19,100 | -52,937 | -60,890 | -40,883 | -193,790 |
| Income Tax | 16,414 | -1,850 | -5,603 | 11,660 | -12,933 |
| Net Income Continuous | -35,514 | -51,087 | -55,287 | -52,543 | -180,857 |
| Net Income | $-35,514 | $-51,087 | $-55,287 | $-52,543 | $-180,857 |
| EPS Basic Total Ops | -0.71 | -1.02 | -1.13 | -1.15 | -4.26 |
| EPS Basic Continuous Ops | -0.71 | -1.02 | -1.13 | -1.15 | -4.26 |
| EPS Diluted Total Ops | -0.71 | -1.02 | -1.13 | -1.15 | -4.26 |
| EPS Diluted Continuous Ops | -0.71 | -1.02 | -1.13 | -1.15 | -4.26 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -1.02 | -1.13 | -1.09 | -4.19 |
| EBITDA(a) | $-42,087 | $-66,257 | $-55,559 | $-46,373 | $-176,219 |